causal

Diminishing returns as risk decreases require bigger trials

As you move down to lower-risk populations and additional doses, the benefit signal shrinks, requiring larger and larger randomized trials to detect it; yet the regulatory system has demanded less and less data as it has moved along to boosters and second boosters.

causalpending

Speaker

Vinay Prasad

Evidence Quote

“the way in medicine we typically sort these out is larger and larger randomized trials. You're looking for smaller and smaller signals. You need larger and larger sample size. Though what we found with the regulatory system around vaccines and boosters... is as we've moved along, we've gotten less and less data.”

Source

Vinay Prasad on the Pandemic— EconTalk
Created: 6/13/2026, 12:17:03 AM

Your notes

Loading notes...